Decoy Share Price
NASDAQ: DCOY | Micro Cap | HealthcareDecoy Stock Performance
Decoy Share Price Chart
Decoy Quarterly Profit & Loss
All figures in USD
Corporate Actions
About Decoy
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
Decoy Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.07 | $0.80 | -25.93% |
Oct 2026 | $1.92 | $1.08 | -45.04% |
Sep 2026 | $2.89 | $1.97 | -35.36% |
Aug 2026 | $4.20 | $3.04 | -25.31% |
Jul 2026 | $6.29 | $4.07 | -44.78% |
Jun 2026 | $9.09 | $7.37 | -6.23% |
May 2026 | $5.49 | $7.86 | +41.88% |
Apr 2026 | $6.27 | $5.54 | -17.44% |
Mar 2026 | $0.68 | $6.71 | +879.56% |
Feb 2026 | $0.69 | $0.69 | -11.27% |
Jan 2026 | $0.80 | $0.77 | N/A |